Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardent Health (ARDT) Common Equity (2023 - 2025)

Ardent Health (ARDT) has 3 years of Common Equity data on record, last reported at $1.2 billion in Q3 2025.

  • For Q3 2025, Common Equity fell 10.56% year-over-year to $1.2 billion; the TTM value through Sep 2025 reached $1.2 billion, down 10.56%, while the annual FY2024 figure was $1.5 billion, 41.51% up from the prior year.
  • Common Equity reached $1.2 billion in Q3 2025 per ARDT's latest filing, down from $1.6 billion in the prior quarter.
  • Across five years, Common Equity topped out at $1.6 billion in Q2 2025 and bottomed at $1.1 billion in Q2 2023.
  • Average Common Equity over 3 years is $1.3 billion, with a median of $1.2 billion recorded in 2024.
  • The widest YoY moves for Common Equity: up 42.2% in 2025, down 10.56% in 2025.
  • A 3-year view of Common Equity shows it stood at $1.1 billion in 2023, then soared by 41.51% to $1.5 billion in 2024, then dropped by 18.6% to $1.2 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were $1.2 billion in Q3 2025, $1.6 billion in Q2 2025, and $1.6 billion in Q1 2025.